Medical Equipment

Telix Reports Third Quarter 2026 Financial Performance

MELBOURNE, Australia and INDIANAPOLIS, Oct. 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a financial update on its commercial and operational performance for the quarter ended September 30, 2026 (Q3 2026). Q3 2026 Highlights[1] * Group reven...

2026-10-21 06:08 5247

Hospital Authority appreciates generous donation from Sino Group and Ng Teng Fong Charitable Foundation

HONG KONG, Oct. 20, 2026 /PRNewswire/ -- The Hospital Authority (HA) today (October 20) extends its heartfelt gratitude to Sino Group and Ng Teng Fong Charitable Foundation for their generous donation of a combined total of $30 million to support the establishment of two operating theatres dedica...

2026-10-20 18:55 2533

New Innovative Molecular Technology Combination "LAMP + CRISPR" as CE-IVD

A Collaboration Leads to Molecularbiological Innovation MUNICH, Oct. 20, 2026 /PRNewswire/ -- AmplexDiagnostics and Scope Biosciences are proud to introduce a groundbreaking solution in molecular diagnostics. In a new approach, "eazySNP" combines the highly specialized molecular technologies LAM...

2026-10-20 14:10 1174

Health Innovation South West and Helfie AI announce partnership to evaluate digital-first hypertension screening

Findings from real-world settings will add to the evidence base for preventing cardiovascular disease MELBOURNE, Australia, Oct. 19, 2026 /PRNewswire/ -- Helfie AI and UK-based Health Innovation South West have announced a partnership to explore how digital-first approaches to hypertension scree...

2026-10-19 17:00 3532

Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.

* Collaboration establishes a framework for a dedicated U.S. source of astatine-211 (211At), a scarce, next-generation alpha-emitting isotope with significant potential in targeted alpha therapy (TAT). * Secures long-term, priority isotope access for Telix's alpha therapy pipeline, including ...

2026-10-19 13:30 2369

HISTOINDEX AND A*STAR PARTNER TO ADVANCE EARLY-STAGE DEVELOPMENT OF PIPELINE THERAPIES FOR FIBROTIC DISEASES

SINGAPORE, Oct. 19, 2026 /PRNewswire/ -- HistoIndex, a pioneer in AI-driven digital pathology for fibrotic diseases, and the Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, have signed a Memorandum of Understanding (MoU) to collaborate on the precl...

2026-10-19 11:00 3823

Abu Dhabi Health Delegation Concludes Inaugural Visit to China, Opening New Pathways to Advance AI, Precision Medicine and Next-Gen Therapies

ABU DHABI, UAE, Oct. 18, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has concluded its inaugural health and life sciences mission to China, advancing priority areas of collaboration designed to accelerate the translation ...

2026-10-18 01:54 6049

Four Leading Institutions Complete Initial Clinical Experience with Spectrum Dynamics Medical's All-Energy Digital SPECT/CT

Experience at institutions from across the globe demonstrated theranostics and imaging across the validated 40-400 keV range and up to 500 keV, with additional scientific and clinical feasibility experience obtained at higher energies, including applications involving Tc-99m, I-123, Lu-177, I-131...

2026-10-15 20:00 2359

HMI Medical Unveils New Brand Identities Across Its Healthcare Facilities in Malaysia As Regional Cross-border Healthcare Grows

The refreshed identities of HMI Medical's hospitals and medical centre in Malaysia signal the Group's commitment to deliver more with care by sparking change for the future of healthcare SINGAPORE and KUALA LUMPUR, Malaysia, Oct. 15, 2026 /PRNewswire/ -- HMI Medical is strengthening its regional...

2026-10-15 12:25 3586

NTL HEALTHCARE Launches On-Premises AI Solution 'CerviCARE® AI AT' Globally

Supports Local AI Analysis and Data Management, Retains Core CerviCARE® AI Features, and Adds DICOM File Generation SEONGNAM, South Korea, Oct. 15, 2026 /PRNewswire/ -- NTL HEALTHCARE, a women's health AI company, announced the global launch of CerviCARE® AI AT, an on-premises version of its AI-...

2026-10-15 10:00 2308

Telix Highlights Pivotal Trials in Prostate, Brain and Renal Cancers and Next Generation Theranostics at EANM

MELBOURNE, Australia and INDIANAPOLIS, Oct. 14, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that 20 company-related abstracts will be presented at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM) to be held in ...

2026-10-14 13:00 2930

The Right Doctor Isn't Always One Doctor

Why complex brain and spine conditions increasingly call for specialists to work across disciplines.   KUALA LUMPUR, Malaysia, Oct. 13, 2026 /PRNewswire/ -- When faced with a brain, spine or neurological condition, one of the first questions a patient or family member may ask is: Which doctor sh...

2026-10-13 16:15 1695

SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease

LUCERNE, Switzerland and NEW DELHI, Oct. 13, 2026 /PRNewswire/ -- The SPARX Global Randomized Controlled Trial (RCT) has been officially initiated, marking the launch of the multinational randomized trial evaluating a drug-coated balloon (DCB)-first strategy against contemporary drug-eluting sten...

2026-10-13 02:11 3330

Fair2Care: Canton Fair Launches International Medical Experience for the First Time

GUANGZHOU, China, Oct. 12, 2026 /PRNewswire/ -- The 140th Canton Fair will open on October 15 with a brand-new experience for attendees. For the first time, the Fair is introducing an exclusive Fair2Care International Medical Experience Program. The program features a dual experience model that c...

2026-10-12 21:01 2989

T-MAXIMUM's B7-H3-Targeted Allogeneic CAR-T MT027 Receives FDA Clearance for Phase 2 Study in Brain Metastases from Lung and Breast Cancer

BEIJING, Oct. 12, 2026 /PRNewswire/ -- T-MAXIMUM PHARMACEUTICAL ("T-MAXIMUM") today announced that the U.S. Food and Drug Administration (FDA) has cleared the company to initiate a Phase 2 clinical study of MT027, its internally developed, B7-H3-targeted universal (allogeneic) CAR-T therapy, for ...

2026-10-12 18:50 2063

Three Korean Deep-Tech Firms Seek Singapore Partners in October

The pre-screened companies span smart-city positioning, AI cardiac screening and functionalcoatings,withSingaporemeetingsplannedfor26-29October. SINGAPORE, Oct. 12, 2026 /PRNewswire/ -- Three technology companies supported by the Incheon Center for Creative Economy & Innovation (Incheon CCEI) - I...

2026-10-12 10:00 4497

RingConn Receives FDA 510(k) Clearance for Non-Invasive Blood Oxygen (SpO2) Measurement

Shenzhen, China, Oct. 10, 2026 /PRNewswire/ -- Shenzhen Ninenovo Technology Limited, the parent company of RingConn, announced that its Smart Ring has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for non-invasive blood oxygen (SpO2) measurement (Clearance No. K260490...

2026-10-10 15:52 3454

Invetech & MeMed win 2026 Good Design Award Gold for MeMed Key™

Award recognizes innovation, design excellence, and impact in Engineering Design SAN DIEGO, Oct. 9, 2026 /PRNewswire/ -- Invetech, a product realization company that designs, engineers and manufactures fully customizable platforms, announced that its work on the MeMed Key™ has been recognized wit...

2026-10-10 04:00 2800

MIDEA COMPLETES THE ACQUISITION OF ESAOTE

Midea Group marks its commitment to healthcare and innovation by completing the acquisition of Esaote   GENOA, Italy, Oct. 9, 2026 /PRNewswire/ -- Esaote S.p.A., a leader in the medical imaging sector, announces the completion of the controlling stake acquisition of its share capital by Midea – ...

2026-10-09 18:00 2720
12345 ... 94